课题基金 / 基金详情

FLAVONOIDS BLOCK SULFATION-INDUCED CARCINOGEN ACTIVATION

FLAVONOIDS BLOCK SULFATION-INDUCED CARCINOGEN ACTIVATION
黄酮类化合物可阻止硫酸化引起的致癌物质激活
批准号:
2608143
负责人:
THOMAS WALLE
金额:
$19.49万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-01-27 至 1999-11-30

项目摘要

项目成果

THOMAS WALLE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The long-term goal of this project is to increase understanding of how dietary constituents may influence the multiple processes of carcinogenesis. The hypothesis is that flavonoids in plant food and beverages are potent inhibitors of human sulfotransferases (STs), enzymes known to catalyze the formation of reactive sulfuric acid esters of many common carcinogens, thereby preventing DNA binding, mutagenesis and carcinogenesis. Aim 1 will investigate the structure-activity relationship and kinetics for inhibition of human P form phenol-ST (P-PST) and dehydroepiandrosterone-ST (DHEA-ST) by flavonoids, using recombinant enzymes, model substrates for P-PST and DHEA-ST and HPLC techniques. Aim 2 will determine the inhibitory effect of the most potent flavonoids on the sulfoconjugation and bioactivation of known human mutagens/carcinogens, e.g. the cooked-food mutagen N-hydroxy-PhIP as a substrate for P-PST and the polyaromatic hydrocarbon 1-hydroxymethyl-pyrene as a substrate for DHEA-ST. Aim 3 will determine the inhibitory effect of flavonoids on other human STs, including estrogen-ST, associated with estrogen metabolism and possibly also carcinogen bioactivation, and M-PST, associated with biogenic amine metabolism, both soluble enzymes. It will also include the membrane-bound tyrosylprotein-ST, associated with posttranslational modification of peptides. Aim 4 will determine the inhibitory effects of the most potent flavonoids on P-PST, DHEA-ST and estrogen-ST in intact cells, i.e. the human hepatoma cell Hep G2 and human liver slices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FLAVONOID BIOAVAILABILITY IN HUMANS - CELLULAR STUDIES
RESVERATROL BIOAVAILABILITY--PRECLINICAL AND CLINICAL
RESVERATROL BIOAVAILABILITY--PRECLINICAL AND CLINICAL
FLAVONOID BIOAVAILABILITY IN HUMAN CELLULAR STUDIES